Vascular & Endovascular: Stroke after TAVR | The risks of excessive cannabis use | Bivalirudin vs. heparin

Post-TAVR stroke is rare, but it can be fatal. A new study in Catheterization and Cardiovascular Interventions examined the issue in great detail, focusing on more than 2,700 patients treated over a two-year stretch. 

Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder. 

Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 

The total value of the acquisition, first announced in 2022, is dependent on various regulatory and commercial milestones.

The biggest differences between the two treatment options were major bleeding events and all-cause mortality. There was no significant difference when it came to stroke risk. 

The two anticoagulants are associated with similar mortality rates. However, a new meta-analysis in Circulation may have cardiologists favoring bivalirudin over heparin. 

Researchers examined two-year data from transfemoral TAVR patients treated with low-dose aspirin and 30 days of warfarin or just aspirin on its own.